Femasys is trading 6.28% up at $2.69, with the after-hours gain appearing aligned with broad risk-on sentiment.

  • It closed at $2.53 on September 21, 2026.
  • No new company-specific announcement dated September 20–21 was identified; the latest notable update was September 15, when Minnesota Women’s Care adopted Femasys’s fertility portfolio across four locations.
  • On September 21, the S&P 500 rose 1.62% and Nasdaq Composite 2.18%. Confidence is medium because the company-specific catalyst remains unclear.